Chimura T, Morisaki N, Goto T, Inoue K, Funayama T
Jpn J Antibiot. 1983 Sep;36(9):2450-4.
Clinical study on cefotetan (CTT), a new cephamycin antibiotic, was carried out and the following results were obtained. CTT was intravenously administered at a daily dose of 2 to 4 g to 24 cases including 10 cases with intrauterine infection, 2 cases with adnexitis, 6 cases with intrapelvic infection and 6 cases with extragenital infection. Marked response was seen in 8 cases, moderate response in 15 and no response in 1. Neither side effects nor abnormal values in clinical laboratory tests were observed.
对新型头孢霉素类抗生素头孢替坦（CTT）进行了临床研究，获得了以下结果。对24例患者静脉注射CTT，日剂量为2至4克，其中包括10例子宫内感染患者、2例附件炎患者、6例盆腔内感染患者和6例生殖器外感染患者。8例患者有显著反应，15例反应中等，1例无反应。未观察到副作用，临床实验室检查也未出现异常值。
